Safety, Pharmacokinetics, and Efficacy of Subcutaneous Isatuximab in Adults With Warm Autoimmune Hemolytic Anemia (wAIHA)

NCT04661033 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
8
Enrollment
INDUSTRY
Sponsor class

Stopped Study discontinuation based on strategic sponsor decision; not driven by any safety concerns.

Conditions

Interventions

Sponsor

Sanofi